Dydrogesterone - Menopausal disorders

You are here : Home > Formulary Search > Dydrogesterone - Menopausal disorders

I agree that in using this database I understand that this platform only provides guidance on local prescribing policy and that all prescribing decisions are ultimately the responsibility of the clinician.

Status 1

See narrative

Formulations :

Tablets

Formulary Status :

Primary Care

ASPH

RSFT

SASH

SABP

Associated Icons :

Guidelines

NFD2

SPC

Restrictions / Comments :

Important

This drug has not been assessed for inclusion on the formulary. Please contact your pharmacy team for advice.

Documentation

No records returned.

PAD Profile

ChemicalSubstance :

Dydrogesterone

Indication :

Menopausal disorders

Group Name :

Keywords :

Menopause, menopausal symptoms, HRT, hormone replacement therapy, progesterone analogue, progestogen, adjunctive progestogen, endometrial protection

Brand Names Include :

Nalvee

Important Information :

Latest Additions Date From :

Latest Additions Date To :

Guidelines :

Menopausal disorders

Supporting Documents :

Other Indications

Below are listed other indications that Dydrogesterone is used to treat.

Menstrual symptoms

Other Drugs

Below are listed other drugs that are used to treat Menopausal disorders.

Committee Recommendations (1)

03 Sep 25 - Not Set

This drug has not yet been assessed for formulary status and is not currently on the APC work-plan.

This drug has not yet been evaluated by the Surrey Heartlands ICS Area Prescribing Committee (APC). As such, advice regarding safety, effectiveness (including cost-effectiveness) and its place in therapy is yet to be determined.

Before prescribing, it is recommended that clinicians contact their Medicines Optimisation team to discuss possible alternatives/options.

The APC will consider recommending the prescribing of this treatment upon submission of a formal request with its associated evidence. Clinicians can contact syheartlandsicb.APC@nhs.net if they wish to make a submission.